Vicarious Trauma: Preventing, Recognizing Its Effects in Oncology Clinicians
A review of how vicarious trauma develops in helping professionals such as oncology nurses, and some preventive measures to mitigate its effects.
Home
Extended IVAD Flush Intervals Increase Potential for Abnormalities in Reservoir Contents
Results of an observational pilot study demonstrate the effects of interval duration on presence of abnormalities in implanted vascular access device reservoirs.
Ruxolitinib Shows Promise in Treatment-Resistant PV
Researchers sought to determine whether ruxolitinib would improve clinical outcomes in patients with treatment-resistant PV.
Simple Screener Can Identify Need for Resource Support in Families With SCD
Researchers sought to determine whether the Psychosocial Assessment Tool would be able to identify families of patients with SCD in need of resource support.
Childhood Cancer Survivors Have Higher Risk of Late Surgical Interventions
Childhood cancer survivors have a higher risk of requiring surgical interventions up to 35 years after diagnosis, a large study suggests.
Aromatherapy Improved Management of Chemotherapy-Induced Nausea and Vomiting
Randomized trial compared effects of ginger oil, peppermint oil, and canola oil on CINV in patients receiving chemotherapy prior to bone marrow transplantation.
2015 to 2019 Saw Increase in ED Use of CTPA for Suspected Pulmonary Embolism
The researchers found that from 2015 to 2019, there were significant trends for more frequent use of CTPA (836 to 1,112 per 100,000 emergency department visits).
Caring for the Caregivers of Patients With Hematologic Malignancies Undergoing HSCT
Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.
Machine Learning Algorithm Shows Promise in Determining BMF Etiology
Researchers sought to determine whether a novel machine learning algorithm could help determine whether a patient has inherited or immune/acquired BMF.
Pirtobrutinib Produces Durable Responses in Relapsed/Refractory MCL
Pirtobrutinib has shown clinical activity in a phase 1/2 trial of patients with relapsed or refractory mantle cell lymphoma.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...